Burning Rock Biotech Limited Selling and Marketing Expense
Burning Rock Biotech Limited (BNR) reported Selling and Marketing Expense of CNY 165.18 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-28.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingAndMarketingExpense · last filed 2026-04-28
CNY
| Period end | Selling and Marketing Expense 6 month | Selling and Marketing Expense 12 month |
|---|---|---|
| 2025-12-31 | 165.18M CNY 20-F · filed 2026-04-28 | |
| 2024-12-31 | 190.90M CNY 20-F · filed 2026-04-28 | |
| 2023-12-31 | 247.71M CNY 20-F · filed 2026-04-28 | |
| 2022-12-31 | 370.29M CNY 20-F · filed 2025-04-29 | |
| 2022-06-30 | 194.84M CNY 6-K · filed 2022-11-07 | |
| 2021-12-31 | 303.10M CNY 20-F · filed 2024-04-29 | |
| 2021-06-30 | 123.19M CNY 6-K · filed 2022-11-07 | |
| 2020-12-31 | 168.59M CNY 20-F · filed 2023-04-20 | |
| 2019-12-31 | 153.33M CNY 20-F · filed 2022-04-29 | |
| 2018-12-31 | 102.86M CNY 20-F · filed 2021-03-23 |
USD
| Period end | Selling and Marketing Expense 6 month | Selling and Marketing Expense 12 month |
|---|---|---|
| 2025-12-31 | $23.62M 20-F · filed 2026-04-28 | |
| 2024-12-31 | $26.15M 20-F · filed 2025-04-29 | |
| 2023-12-31 | $34.89M 20-F · filed 2024-04-29 | |
| 2022-12-31 | $53.69M 20-F · filed 2023-04-20 | |
| 2022-06-30 | $29.09M 6-K · filed 2022-11-07 | |
| 2021-12-31 | $47.56M 20-F · filed 2022-04-29 | |
| 2020-12-31 | $25.84M 20-F · filed 2021-03-23 |